evocalcet (PD050932, RZNUIYPHQFXBAN-XLIONFOSSA-N)

General

Preferred name

evocalcet

Synonyms

KHK7580

MT-4580

KHK-7580

P&D ID

PD050932

CAS

870964-67-3

Tags

available

drug

Approved by

PMDA

First approval

2018

Drug Status

approved

investigational

Max Phase

3.0

Structure

PD050932

evocalcet

approved

RO5

374.2

HBA

HBD

LOGP

4.4

Structure formats

SMILES

C[C@@H](N[C@H]1CCN(c2ccc(CC(=O)O)cc2)C1)c1cccc2ccccc12

InChI

InChI=1S/C24H26N2O2/c1-17(22-8-4-6-19-5-2-3-7-23(19)22)25-20-13-14-26(16-20)21-11-9-18(10-12-21)15-24(27)28/h2-12,17,20,25H,13-16H2,1H3,(H,27,28)/t17-,20+/m1/s1

InChIkey

RZNUIYPHQFXBAN-XLIONFOSSA-N

MOL

evocalcet RDKit 2D 28 31 0 0 0 0 0 0 0 0999 V2000 -3.7500 -3.8971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.0000 -2.5981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.7500 -1.2990 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -5.2500 -1.2990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.1317 -2.5126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -7.5583 -2.0490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -7.5583 -0.5490 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -8.7718 0.3326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -8.6150 1.8244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -9.8285 2.7061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -11.1988 2.0960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -12.4124 2.9777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -12.2556 4.4695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -10.8853 5.0796 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -13.4691 5.3511 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -11.3556 0.6042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -10.1421 -0.2775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.1317 -0.0855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.5000 -2.5981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7500 -3.8971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7500 -3.8971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.5000 -2.5981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7500 -1.2990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.5000 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7500 1.2990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7500 1.2990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.5000 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7500 -1.2990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 1 2 3 1 0 4 3 1 1 4 5 1 0 5 6 1 0 6 7 1 0 7 8 1 0 8 9 2 0 9 10 1 0 10 11 2 0 11 12 1 0 12 13 1 0 13 14 2 0 13 15 1 0 11 16 1 0 16 17 2 0 7 18 1 0 2 19 1 0 19 20 2 0 20 21 1 0 21 22 2 0 22 23 1 0 23 24 2 0 24 25 1 0 25 26 2 0 26 27 1 0 27 28 2 0 18 4 1 0 28 19 1 0 17 8 1 0 28 23 1 0 M END > <ID> PD050932 > <Name> evocalcet

Description

(extracted from source data)

DESCRIPTION Evocalcet is an investigational calcium-sensing receptor (CASR) agonist, or calcimimetic. CASR is a G protein-coupled receptor.
This compound is claimed in patent US8362274 . (GtoPdb)

Protein targets

7.03

CASR Extracellular calcium-sensing receptor allosteric modulatorpositive allosteric modulator